Why are you looking at Auravax Therapeutics?
Email me when a Auravax Therapeutics recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Work mix: 100% prime · 0% sub · primary NAICS 541714 / PSC AN14 HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES
Where they win
Sole agencyRecompete exposure: Low · 1 in 24mo
Auravax Therapeutics has an estimated $750K in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
LowAuravax Therapeutics has an estimated $750K in contracts returning to market over the next 24 months. 1 within 6 months ($750K).
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Auravax Therapeutics hold?
Auravax Therapeutics (UEI PAN3ZK2YLAL2) shows $750K across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Auravax Therapeutics have?
Auravax Therapeutics shows $750K across 1 award actions. SCOUT tracks 1 incumbent recompetes ($750K) returning to market in the next 24 months.
Which agencies does Auravax Therapeutics work with?
Auravax Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
What is the UEI for Auravax Therapeutics?
The Unique Entity ID (UEI) for Auravax Therapeutics is PAN3ZK2YLAL2.
Does Auravax Therapeutics have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Auravax Therapeutics, — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.